Asciminib Roll-over Study

Recruiting now · Phase 4

Conditions studied: Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

In brief

This is a long term safety study for patients who have completed a Novartis sponsored asciminib study and are judged by the investigator to benefit from continued treatment

Key facts

Study ID

NCT04877522

Run by

Novartis Pharmaceuticals

People needed

347

Starts

2022-08-30

Expected to finish

2030-08-30

Last updated by the study team

2026-07-06

Who can join

Age: 7 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Novartis Investigative Site — Ostrava, Poruba, Czechia (enrolling)
• Novartis Investigative Site — Lyon, France (enrolling)
• Texas Oncology — Dallas, Texas, United States (enrolling)
• Novartis Investigative Site — Tianjin, China (enrolling)
• Novartis Investigative Site — Bordeaux, France (enrolling)
• Novartis Investigative Site — CABA, Buenos Aires, Argentina (enrolling)
• Novartis Investigative Site — Capital Federal, Argentina (enrolling)
• Novartis Investigative Site — Graz, Austria (enrolling)
• Novartis Investigative Site — Vienna, Austria (enrolling)
• Novartis Investigative Site — Shenyang, China (enrolling)
• Novartis Investigative Site — Brno, Czechia (enrolling)
• Michigan Med University of Michigan — Ann Arbor, Michigan, United States (enrolling)
• Novartis Investigative Site — Varna, Bulgaria (enrolling)
• Novartis Investigative Site — Montreal, Quebec, Canada (enrolling)
• Novartis Investigative Site — Chongqing, Chongqing Municipality, China (enrolling)
• Novartis Investigative Site — Guangzhou, Guangdong, China (enrolling)
• Novartis Investigative Site — Zhengzhou, Henan, China (enrolling)
• Novartis Investigative Site — Wuhan, Hubei, China (enrolling)
• Novartis Investigative Site — Changchun, Jilin, China (enrolling)
• Novartis Investigative Site — Xian, Shanxi, China (enrolling)
• Uni Of TX MD Anderson Cancer Cntr — Houston, Texas, United States (enrolling)
• Memorial Sloan Kettering — New York, New York, United States (enrolling)
• Novartis Investigative Site — Beijing, China (enrolling)
• Medical College of Wisconsin — Milwaukee, Wisconsin, United States (enrolling)
• Novartis Investigative Site — Marseille, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.